{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-essential-documents-during-trial-ich-e6-section-8”
},
“headline”: “SOP for Essential Documents During Trial (ICH E6 §8)”,
“description”: “This SOP defines the essential documents required to be filed and maintained during the conduct of a clinical trial, in compliance with ICH E6 §8 and global regulatory requirements, including protocols, approvals, monitoring reports, safety records, IP logs, consent forms, and training documentation.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Essential Documents During Trial (ICH E6 §8)

Purpose

The purpose of this SOP is to define the process for collecting, filing, and maintaining essential documents during the conduct of a clinical trial, as per ICH E6 §8 requirements. These documents collectively enable the evaluation of trial conduct and ensure compliance with GCP, regulatory expectations, and subject protection.

Scope

This SOP applies to sponsors, CROs, investigators, site staff, and QA responsible for maintaining essential documents in the TMF and ISF during the trial. It covers monitoring reports, approvals, informed consent forms, IP accountability logs, correspondence, safety reporting, and other trial-related documentation.

Responsibilities

• Sponsor: Ensures TMF is complete and contemporaneous.
• CRO: Maintains documents delegated by sponsor under oversight.
• Investigator: Maintains ISF and subject-level essential documents.
• CRA: Collects and files monitoring reports, logs, and site-level records.
• QA: Audits TMF and ISF to ensure inspection readiness.
• TMF Administrator: Classifies, indexes, and files documents with quality checks.

Accountability

The Head of Clinical Operations is accountable for overall TMF maintenance during the trial. Investigators are accountable for ISF completeness. QA is accountable for verifying inspection readiness.

Procedure

1. Protocol and Amendments
1.1 File final approved protocol and all subsequent amendments.
1.2 Ensure all amendments are approved by EC/IRB and regulatory authorities.

2. Informed Consent Documentation
2.1 File signed informed consent forms (ICFs) for each subject.
2.2 Ensure contemporaneous version control and language approvals.
2.3 Maintain ICF Filing Log (Annexure-1).

3. Investigator and Site Documentation
3.1 File updated CVs and training certificates of PI and site staff.
3.2 File updated Delegation of Authority Logs.
3.3 File Investigator communication with sponsor/CRO.

4. Monitoring Documentation
4.1 File monitoring visit reports, follow-up letters, and responses.
4.2 Ensure reconciliation between reports and trial activities.
4.3 Maintain Monitoring Report Log (Annexure-2).

5. Investigational Product Documentation
5.1 File IP accountability logs, receipts, dispensing records, and destruction logs.
5.2 File temperature logs and excursion reports.
5.3 Maintain IP Accountability Log (Annexure-3).

6. Safety Documentation
6.1 File SAE reports, SUSAR submissions, and follow-up documentation.
6.2 File DSUR/PSUR submissions and safety committee communications.
6.3 Maintain Safety Reporting Log (Annexure-4).

7. Subject-Level Documentation
7.1 File subject ID logs, screening and enrolment logs.
7.2 File eligibility verification checklists.
7.3 Maintain Subject Tracking Log (Annexure-5).

8. Correspondence and Communication
8.1 File essential correspondence with regulators, ECs/IRBs, CROs, and vendors.
8.2 File minutes of meetings and teleconferences.
8.3 Maintain Correspondence Log (Annexure-6).

9. Training and Qualification
9.1 File training records for staff joining during the trial.
9.2 Maintain GCP training certificates.
9.3 Maintain Training Record Log (Annexure-7).

10. Quality Control
10.1 Perform monthly QC checks on TMF/ISF.
10.2 Document findings in TMF QC Log (Annexure-8).
10.3 Correct discrepancies within 10 working days.

Abbreviations

• SOP: Standard Operating Procedure
• TMF/ISF: Trial Master File / Investigator Site File
• PI: Principal Investigator
• CRA: Clinical Research Associate
• QA: Quality Assurance
• EC/IRB: Ethics Committee / Institutional Review Board
• SAE: Serious Adverse Event
• SUSAR: Suspected Unexpected Serious Adverse Reaction
• DSUR/PSUR: Development Safety Update Report / Periodic Safety Update Report

Documents

1. ICF Filing Log (Annexure-1)
2. Monitoring Report Log (Annexure-2)
3. IP Accountability Log (Annexure-3)
4. Safety Reporting Log (Annexure-4)
5. Subject Tracking Log (Annexure-5)
6. Correspondence Log (Annexure-6)
7. Training Record Log (Annexure-7)
8. TMF QC Log (Annexure-8)

References

• ICH E6(R2/R3) – Essential Documents During Trial
• FDA – TMF Maintenance Guidance
• EMA – TMF and ISF Inspection Guidance
• CDSCO – Essential Documents Filing
• WHO – GCP Essential Documents

Version: 1.0

Approval Section

Annexures

Annexure-1: ICF Filing Log

Annexure-2: Monitoring Report Log

Annexure-3: IP Accountability Log

Annexure-4: Safety Reporting Log

Annexure-5: Subject Tracking Log

Annexure-6: Correspondence Log

Annexure-7: Training Record Log

Annexure-8: TMF QC Log

Revision History

For more SOPs visit: Pharma SOP

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-tmf-setup-paper-etmf-and-structure”
},
“headline”: “SOP for TMF Setup (Paper/eTMF) and Structure”,
“description”: “This SOP establishes standardized processes for setting up Trial Master Files (TMF), both paper and electronic (eTMF), ensuring compliance with ICH GCP, FDA, EMA, CDSCO, and WHO requirements for clinical trial documentation structure, indexing, and inspection readiness.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for TMF Setup (Paper/eTMF) and Structure

Purpose

The purpose of this SOP is to describe the standardized setup, structure, and maintenance of the Trial Master File (TMF), whether maintained in paper format or electronic format (eTMF). TMF serves as the central repository of essential documents demonstrating compliance with Good Clinical Practice (GCP) and enabling evaluation by regulatory authorities.

Scope

This SOP applies to sponsors, CROs, investigator sites, and QA staff responsible for establishing, maintaining, and overseeing TMF/eTMF systems. It covers setup, indexing, placeholders, document classification, version control, user access, quality checks, and inspection readiness across all clinical trials.

Responsibilities

• Sponsor: Ensures TMF/eTMF is established, structured, and compliant with ICH GCP.
• CRO: May maintain TMF on behalf of sponsor but sponsor retains oversight responsibility.
• Clinical Operations: Files trial-related documents, ensures contemporaneous updates.
• QA: Audits TMF/eTMF for compliance and completeness.
• TMF Administrator: Manages indexing, placeholders, user access, and quality checks.
• Investigators: Ensure ISF aligns with sponsor TMF.

Accountability

The sponsor is accountable for TMF/eTMF compliance, regardless of outsourcing. TMF administrators and CROs are accountable for daily management, while QA ensures oversight and audit readiness.

Procedure

1. TMF/eTMF Setup
1.1 At trial initiation, establish a TMF in accordance with ICH E6 (R2/R3) §8 Essential Documents.
1.2 Define TMF structure using recognized models (e.g., DIA TMF Reference Model).
1.3 For eTMF, validate the system in compliance with 21 CFR Part 11 and Annex 11.
1.4 Create TMF/eTMF Index (Annexure-1) reflecting trial phases: before, during, and after the trial.
1.5 Ensure placeholders are created for expected documents, reducing missing documentation risk.

2. Document Classification and Filing
2.1 Classify each document as Essential Before, During, or After trial per ICH GCP.
2.2 Assign document owners responsible for timely filing.
2.3 File documents within 5 working days of finalization.
2.4 Apply version control; superseded versions archived with audit trail.
2.5 Scan and upload paper documents into eTMF if hybrid system used.

3. User Access and Security
3.1 Provide role-based access controls for TMF/eTMF.
3.2 Ensure inspectors have read-only access when required.
3.3 Maintain Access Control Log (Annexure-2).

4. Quality Control and Completeness Checks
4.1 Perform monthly QC checks on 10% of documents across sections.
4.2 Document QC results in TMF QC Log (Annexure-3).
4.3 Rectify discrepancies within 10 working days.
4.4 Perform quarterly completeness reviews using DIA TMF metrics.

5. Version Management and Audit Trails
5.1 Ensure all eTMF documents have audit trails (creation, modification, deletion).
5.2 For paper TMFs, apply dated/stamped superseded labels.
5.3 Maintain TMF Audit Trail Log (Annexure-4).

6. Inspection Readiness
6.1 TMF/eTMF must be inspection-ready at all times.
6.2 Maintain TMF Inspection Checklist (Annexure-5).
6.3 Ensure essential documents (consent, approvals, monitoring reports, IP accountability) are contemporaneous.
6.4 Provide controlled access for regulators within 5 working days of request.

7. Archiving and Migration
7.1 Archive TMF/eTMF at trial closeout in secure, access-controlled facility.
7.2 Retain documents for 15–25 years depending on jurisdiction.
7.3 Document any migration from paper to eTMF or between systems with validation and reconciliation records.

Abbreviations

• SOP: Standard Operating Procedure
• TMF/eTMF: Trial Master File / electronic Trial Master File
• QC: Quality Control
• QA: Quality Assurance
• DIA: Drug Information Association
• PI: Principal Investigator
• ISF: Investigator Site File

Documents

1. TMF/eTMF Index (Annexure-1)
2. Access Control Log (Annexure-2)
3. TMF QC Log (Annexure-3)
4. TMF Audit Trail Log (Annexure-4)
5. TMF Inspection Checklist (Annexure-5)

References

• ICH E6(R2/R3) – Essential Documents
• FDA – TMF and eTMF Guidance
• EMA – TMF Requirements
• CDSCO – TMF Guidelines
• WHO – TMF Management

Version: 1.0

Approval Section

Annexures

Annexure-1: TMF/eTMF Index

Annexure-2: Access Control Log

Annexure-3: TMF QC Log

Annexure-4: TMF Audit Trail Log

Annexure-5: TMF Inspection Checklist

Revision History

For more SOPs visit: Pharma SOP